Nirmish Singla

9PUBLICATIONS
59CO-AUTHORS
Clinical pharmacology and therapeuticsPredictive and prognostic markersCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 14, 2026
Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States.

|Mar 25, 2025
Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity.

Roy Elias, Thomas Nirschl, Michael Rezaee

|Mar 14, 2025
The role of the urinary microbiome in genitourinary cancers.

Seoho Lee, Karen Sfanos, Nirmish Singla

|May 03, 2024
Plasma Kidney Injury Molecule-1 for Preoperative Prediction of Renal Cell Carcinoma Versus Benign Renal Masses, and Association With Clinical Outcomes.

Wenxin Xu, Valerie Gaborieau, Samuel M Niman

|Sep 08, 2022
ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma.

Aditi Mulgaonkar, Roy Elias, Layton Woolford

|Jul 21, 2021
Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma.

Andrew W Silagy, Ritesh R Kotecha, Stanley Weng

Pageof 2

Frequent Collaborators

2 joint publications

Joseph G Cheaib

2 joint publications

Yair Lotan

2 joint publications

Roy Elias

2 joint publications

I Alex Bowman